Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Wedzicha (London, United Kingdom). Antiviral defences in chronic obstructive lung diseases. Annual Congress 2006 - Infections and chronic obstructive lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Chronic obstructive lung diseases Source: Eur Respir Monogr 2014; 66: 199-217 Year: 2014 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Respiratory rehabilitation in the chronic obstructive lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006 Emerging drugs in chronic obstructive pulmonary disease Source: Annual Congress 2010 - Emerging drugs in COPD Year: 2010 Bacterial bronchopulmonary infection-induced exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002 Mucus production in chronic obstructive lung diseases: relationship with infections Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 The burden of obstructive lung diseases Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 The burden of obstructive lung diseases Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 Immune checkpoints in chronic obstructive pulmonary disease Source: Eur Respir Rev, 26 (144) 170045; 10.1183/16000617.0045-2017 Year: 2017 Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Inflammation and depression in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 718s Year: 2007 Respiratory rehabilitation in the chronical obstructive lung diseases and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 321s Year: 2004 Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Antioxidant properties of ambroxol in chronic obstructive pulmonary disease Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Immunomodulatory efficacy of inferon in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: management Year: 2010 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007